Our proprietary Lipid-enabled and Unlocked Nucleic Acid modified RNA delivery technology (LUNAR™) platform utilizes lipid-enabled technology that is biodegradable and biocompatible. These novel particles have shown excellent safety and potency in multiple animal species. LUNAR utilizes a GMP-ready microfluidic formulation process that yielded small particles (< 80 nm) with a low polydispersity index (< 0.05). This formulation process is scalable and the resulting particles have been shown to be stable.



Mechanism of Action – click to expand

© 2015 Arcturus Therapeutics, Inc.